A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK

In this cohort the highest chance of a positive PsARC response was to 1st line b/tsDMARD: twice the chance of response vs 2nd/3rd line. The chance of a positive PsARC response to 4th+ lines of b/tsDMARD was not significantly different from 2nd/3rd lines after adjustment. This indicates that patients in a UK cohort can continue to have a meaningful response to later lines of treatment. This is the first available evidence of response to later lines of b/tsDMARD treatment in PsA.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2025-11-05
DOI
https://doi.org/10.1093/rheumatology/keaf570
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK

William Tillett, Lija James, Ashley Elliott, Rekha Yadagiri et al.
Lara D. Veeken
Spondyloarthritis Studies and Treatments
article

A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK

William Tillett, Lija James, Ashley Elliott, Rekha Yadagiri, Emily Rose‐Parfitt, Arani Vivekanantham, Tania Gudu, Deepak R. Jadon, Dhivya Das, Theresa Smith, Nicola Gullick, Gayatri Mittal, Philip Helliwell, Jon Packham, Emma Williams, Hoda Mirjafari-Temple, Neil McHugh, Charlotte E Gollins, Laura C. Coates, Caoimhe Fahy, Mel Brooke Turfrey, Chetan Chauhan, Ira Pande, Audrey Russell, Antoni Chan
article en

Abstract

In this cohort the highest chance of a positive PsARC response was to 1st line b/tsDMARD: twice the chance of response vs 2nd/3rd line. The chance of a positive PsARC response to 4th+ lines of b/tsDMARD was not significantly different from 2nd/3rd lines after adjustment. This indicates that patients in a UK cohort can continue to have a meaningful response to later lines of treatment. This is the first available evidence of response to later lines of b/tsDMARD treatment in PsA.

Lara D. VeekenVol. 65(2)
Royal National Hospital for Rheumatic Diseases (GB), University of Leeds (GB), Nuffield Orthopaedic Centre (GB), University Hospitals Coventry and Warwickshire NHS Trust (GB), University of Warwick (GB), University of Oxford (GB), Research Canada (CA), Bath Institute for Rheumatic Diseases (GB), University of Bath (GB)
Openalex Percentile: Top 52%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.